Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,150 | 16,448 | 25,034 | 14,773 | 16,768 |
| TOTAL | $14,159 | $19,182 | $26,056 | $15,880 | $18,159 |
| Non-Current Assets | |||||
| PPE Net | 36 | 41 | 43 | 55 | 65 |
| Intangibles | 120 | 120 | 120 | 120 | 120 |
| Other Non-Current Assets | 693 | 679 | 100 | 0 | 11 |
| TOTAL | $849 | $840 | $263 | $175 | $196 |
| Total Assets | $15,008 | $20,022 | $26,319 | $16,055 | $18,355 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,044 | 1,133 | 1,404 | 1,051 | 1,640 |
| Accrued Expenses | 562 | 498 | 1,251 | 1,295 | 872 |
| TOTAL | $2,047 | $2,011 | $2,655 | $2,346 | $2,512 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 139 | 200 | 0 | 0 | 0 |
| TOTAL | $139 | $200 | $N/A | $N/A | $1 |
| Total Liabilities | $2,186 | $2,211 | $2,655 | $2,346 | $2,513 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,362 | 6,090 | 6,090 | 14,203 | 9,513 |
| Common Shares | 6 | 6 | N/A | 10 | 9 |
| Retained earnings | -200,525 | -194,685 | -188,452 | -180,864 | -175,385 |
| Other shareholders' equity | -39 | -39 | -41 | -29 | -34 |
| TOTAL | $12,822 | $17,811 | $23,664 | $13,709 | $15,842 |
| Total Liabilities And Equity | $15,008 | $20,022 | $26,319 | $16,055 | $18,355 |